3-5 November 2026
RAIAmsterdam, Netherlands Mark EcclestonCEO at ValiRxSpeaker
Profile
Dr Mark Eccleston is CEO of ValiRx Plc, a small cap biotech company listed on London’s AIM market. He's also a director of ValiRx’s subsidiary companies CytoLytix, Inaphaea Biolabs, ValiRx Animal Health and Blue Ribbon Bio. Mark is an entrepreneurial scientist initially trained as a chemist with a focus in drug delivery and holds an MBA. He has founded multiple companies including a diagnostic company listed on the US exchange and took over as CEO of ValiRx in 2024.
Agenda Sessions
Next Generation Oncolytic Peptides - Drivers of Immunogenic Cell Death for Host Immune Activation
, 16:30View Session